Margaret A. Hamburg, M.D.
Commissioner U.S. Food and Drug Administration
NTI | bio Convenes Experts to Establish Global Entity Dedicated to Reducing Biotechnology Risks
An interdisciplinary group of international leaders and experts came together virtually on May 21 to advance the mission and scope of a prospective global entity dedicated to reducing biotechnology risks, promoting global biosecurity norms, and strengthening international oversight of life sciences research. The 15+ experts from international organizations, academia, philanthropy, and biotechnology industry comprise a steering group that will advise NTI | bio on its work to shape the entity’s structure, governance, and relationship to key stakeholders.
The meeting builds on momentum established during a September 2020 meeting convened by NTI Co-Chair and CEO Ernest J. Moniz that brought together global experts to discuss the need to establish an international entity to oversee global biosecurity norms and best practices and to further work to establish an international Common Mechanism for DNA synthesis screening.
The COVID-19 pandemic has highlighted the urgency of these efforts by demonstrating the severe impact of biological events in terms of loss of life, as well as economic and political disruption on a global scale. Adding to the risk: gaps in the global biosecurity architecture regarding governance of bioscience and biotechnology and the increasing threat of deliberate misuse or catastrophic laboratory accidents. A dedicated entity can reduce these risks by developing global biosecurity norms and innovative tools and governance approaches that can be used by industry, academia, governments, and funders in a collective effort to reduce emerging biological risks associated with rapid technology advances.
This project is part of the Biosecurity Innovation and Risk Reduction Initiative (BIRRI). Learn more about BIRRI and related initiatives here.
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
More News
85% of Registered Voters Support the United States Working with China to Mitigate AI Risks, according to New Poll
New YouGov polling commissioned by NTI and ReThink Media finds that nearly 80 percent of registered voters, across party lines, say it is in the interest of U.S. national security to work with China to mitigate catastrophic threats associated with nuclear risks, AI development, and bioterrorism.
NTI, Concordia AI Launch International Working Group to Improve Biological Capability Evaluations
NTI | bio and Concordia AI, with technical input from SecureBio, have launched the AIxBio Technical Working Group on Evaluation Practice. Convened through the AIxBio Global Forum, the Working Group will bring together experts from organizations in China, the European Union, the United Kingdom, and the United States that develop or conduct biological capability evaluations of AI systems.
NTI | bio Engages Global Leaders at GHS2026 in Kuala Lumpur
NTI | bio experts will take part in several GHS2026 sessions, including a preview of findings from the forthcoming Africa Health Security (AHS) Index and a timely discussion on strengthening health security partnerships amid declining resources.
